25 of the Best Oncologists Near Me

Dr. Waina Cheng is a medical oncologist hematologist dedicated to the diagnosis and treatment of all types of cancer and blood disorders. Her primary interest is in breast and colon cancer. She also has extensive experience in diagnosing and treating benign blood conditions. Dr Cheng is board-certified in hematology and oncology. She completed her residency and fellowship training at New York-Presbyterian Hospital in New York City. She received her medical degree from the Icahn School of Medicine at Mount Sinai in New York. Before joining Atlantic Medical Oncology, Dr. Cheng served as assistant professor of clinical medicine at Lincoln Medical Center, affiliated with Weill Cornell Medical College. There, she strived to provide quality cancer care for the underserved immigrant population of the South Bronx community. For her work there, she was awarded a scholarship from the Susan G. Komen and Conquer Cancer Foundation for her commitment to practicing in a medically underserved population. To better improve coordination of care for cancer patients, she served as quality improvement liaison in the cancer committee. Dr. Cheng currently serves as chair of the American College of Surgeons Commission on Cancer-accredited Cancer Committee at Newton Medical Center. She maintains professional membership in the American Society of Clinical Oncology, is a part of the Atlantic Medical Group and is a participating provider of the Atlantic Accountable Care Organization. Dr. Cheng is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, Muscle Invasive Bladder Cancer, and Bone Marrow Aspiration. Dr. Cheng is board certified in American Board Of Internal Medicine. Dr. Cheng is currently accepting new patients.

Melissa K. Yee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center.  She specializes in the treatment of solid tumors and blood disorders.Dr. Yee is board-certified by the American Board of Internal Medicine in medical oncology, hematology, and internal medicine.  She received her medical degree from the Drexel University College of Medicine in Philadelphia. She then completed her internal medicine residency and hematology/oncology fellowship at UPMC. She earned her undergraduate degree from Tufts University. After completion of her medical training, she was on staff at Dana Farber Cancer Institute in Boston before returning to Pittsburgh to practice at UPMC Mercy.Dr. Yee is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology, and Massachusetts Medical Society. Dr. Yee is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Yee is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Yee is currently accepting new patients.

Brian Carney is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Carney is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Carney is board certified in American Board Of Internal Medicine.

Mirna Farhat is a Hematologist and an Oncologist practicing medicine in Dearborn, Michigan. She has been practicing medicine for over 21 years. Dr. Farhat is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Anemia, Pulmonary Embolism, Deep Vein Thrombosis, and Acute Mountain Sickness. Dr. Farhat is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Farhat is currently accepting new patients.

Arun Bhandari, M.D. is a native of Maryland and grew up in Silver Spring area. He earned his medical degree from Punjabi University and Government Medical College, Punjab, India and completed his internship and residency in Internal Medicine at New York University program in Queens, NY. He completed his Hematology and Oncology fellowship at University of Tennessee Health Science Center, Memphis, TN, Georgetown University and Washington Hospital Center, Washington, DC and NHLBI at National Institute of Health, Bethesda, MD. He served as a chief fellow at Georgetown University and Washington Hospital Center, Washington, D.C. After completing his fellowship in 2005, he joined as faculty at Allegheny General Hospital in Pittsburgh, PA, where he was actively involved in teaching fellows and residents. He joined COHA in 2007 at which time he opened a location in Annapolis and Kent Island. He has interest in head and neck cancer, brain cancer, breast cancer, lung cancer, gastrointestinal cancer(colon, pancreas, liver, gastric, esophageal etc.), genitourinary cancer (kidney, prostate, bladder etc.), gynecological cancer (ovarian, uterine, cervical, vaginal etc.), skin cancer, Lymphoma, Myeloma, Leukemia and various other blood disorders. He is a member of the American Society of Clinical Oncology and American Society of Hematology. He currently sees patients at Annapolis Cancer Center and Kent Island Center. He speaks English, Hindi, and Punjabi. Dr. Bhandari is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Multiple Myeloma, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia. Dr. Bhandari is board certified in American Board Of Internal Medicine.

George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at Baylor College of Medicine. Dr. Van Buren is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Gallbladder Adenocarcinoma, Gallbladder Cancer, Splenectomy, and Pancreatectomy. Dr. Van Buren is currently accepting new patients.

Robert Massingill is a Hematologist Oncology provider practicing medicine in Shreveport, Louisiana. Dr. Massingill is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Massingill is board certified in American Board Of Internal Medicine.

Dr. Omar Barakat is a general surgeon specializing in benign and malignant diseases of the liver, bile duct, gallbladder, and pancreas. He is an Associate Professor of Surgery - Division of Surgical Oncology at Baylor College of Medicine and Medical Director of the Neuroendocrine Tumor Program at Baylor St. Luke’s Medical Center.Dr. Barakat’s clinical interests include: malignant hepatobiliary and pancreatic diseases, liver and pancreas surgery; upper gastrointestinal surgery; neuroendocrine tumors; gastrointestinal stromal tumors (GIST); and minimally invasive surgery.Dr. Barakat has developed new surgical techniques to minimize the complication rate and blood loss following pancreatic and liver surgeries. He utilizes image-guided therapies, such as radiofrequency ablation, microwave ablation, irreversible electroporation (NanoKnife system), trans-arterial chemotherapy, and selective internal radiotherapy (SIRT) with Yttrium-90 microspheres, to treat liver tumors while minimizing trauma to the patients. Dr. Barakat's clinical and research interests also include the study of neuroendocrine tumors; and the development of off-the-shelf bio-artificial liver organs that can be suitable for liver transplantation in patients with end-stage liver disease.Dr. Barakat received his medical degree from Aleppo University Medical School in Aleppo, Syria. He completed a residency in general surgery at the Medical College of Pennsylvania, Episcopal Hospital in Philadelphia and a Fellowship in cardiovascular surgery research at State University of New York - Buffalo. He also completed clinical fellowships in liver transplantation at The University of Texas Health Science Center in Houston; and in heart transplantation and mechanical assist devices aat the Texas Heart Institute. He continued his practice in liver and pancreatic surgery at Freeman Hospital in Newcastle Upon-Tyne, United Kingdom, where he treated complex and rare tumors of the liver, bile duct, and pancreas. Dr. Barakat is board-certified by the Royal College of Surgeons (Ed), United Kingdom, where he is also a Fellow. Dr. Barakat is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Bile Duct Stricture, Chronic Pancreatitis, Gallbladder Disease, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Barakat is currently accepting new patients.

Edward Garon is an Oncologist practicing medicine in Santa Monica, California. Dr. Garon is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Geoffrey Oxnard is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Oxnard is highly rated in 11 conditions, according to our data. His clinical expertise encompasses EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy.

Jhanelle Gray is an Oncologist practicing medicine in Tampa, Florida. Dr. Gray is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Gray is currently accepting new patients.

Mark Socinski is an Oncologist practicing medicine in Orlando, Florida. Dr. Socinski is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Socinski is currently accepting new patients.

David Carbone is an Oncologist practicing medicine in Columbus, Ohio. Dr. Carbone is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Tissue Biopsy.

Marina Garassino is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Garassino is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Thymectomy.

Aditya Bardia is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Bardia is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Triple-Negative Breast Cancer, Agranulocytosis, and Tissue Biopsy.

Sang-hoon Ahn is an Oncologist practicing medicine in Los Angeles, California. Dr. Ahn is highly rated in 61 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Stomach Cancer, Breast Cancer, Thrombectomy, and Endoscopy.

Naiyer Rizvi is an Oncologist practicing medicine in New York, New York. Dr. Rizvi is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Gamma Knife Radiosurgery.

Binod Dhakal, MD, MS, is an associate professor of medicine (hematology and oncology) at the Medical College of Wisconsin, specializing in multiple myeloma and plasma cell disorders. He graduated from Manipal College of Medical Sciences, Pokhara Nepal in 2004, completed internal medicine residency at Saint Francis Hospital, Evanston, IL, and a fellowship in hematology/oncology at the Medical College of Wisconsin, where he also served as a chief fellow. Prior to joining the fellowship, he was an assistant professor of medicine (general internal medicine) at the Medical College in Wisconsin. He has authored numerous publications, including journal articles, meeting abstracts and book chapters. He has also won several awards during his fellowship which include the American Society of Clinical Oncology (ASCO) Merit Award; Medical College of Wisconsin Affiliated Hospitals (MCWAH) research award; Central Society for Clinical and Translational Research (CSCTR) best oral abstract and travel trainee award; American Society for Blood and Marrow Transplantation (ASBMT) clinical research training course; and, Outstanding Medical School Teacher award. Additionally, he was the recipient of the Mazie Froedtert Willms and Sue Froedtert Cancer Scholarship, and obtained his Master’s Degree in Clinical and Translational Science. His current research interests focus on novel drug treatments for patients with multiple myeloma and related plasma cell disorders by designing and conducting early phase clinical trials. Dr. Dhakal is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dhakal is currently accepting new patients.

Kenneth Yu is an Oncologist practicing medicine in New York, New York. Dr. Yu is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization. Dr. Yu is currently accepting new patients.

Nikhil Khushalani is an Oncologist practicing medicine in Tampa, Florida. Dr. Khushalani is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Brain Tumor, and Neuroendocrine Tumor. Dr. Khushalani is currently accepting new patients.

Pamela Kunz is an Oncologist practicing medicine in New Haven, Connecticut. Dr. Kunz is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Carcinoid Syndrome, Pancreatic Cancer, and Pancreaticoduodenectomy.

Omid Hamid is a Hematologist and an Oncologist practicing medicine in Los Angeles, California. Dr. Hamid is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Uveal Melanoma.

Dr. Collin Blakely is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments. Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF. Dr. Blakely is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Blakely is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Blakely is currently accepting new patients.

Ragini Kudchadkar is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Kudchadkar is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Basal Cell Skin Cancer, and Melanoma of the Eye.

Douglas McNeel, MD, PhD, is a UW Health medical oncologist and a professor in the Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health, Department of Medicine. He cares for people with prostate, bladder, kidney and testicular cancer using the most advanced treatments available.Dr. McNeel sees himself as a partner, working together with patients and their families to come up with the best treatment plan using the latest therapy options. He’s excited about the progress in cancer care and the treatments now available that didn’t exist just a decade ago.A medical research opportunity in college led Dr. McNeel toward his career as a doctor. He was drawn to the possibility of conducting research that could have a positive impact on the care he provides. He currently leads studies on immune-based treatments, like vaccines, for prostate cancer and is the director of Solid Tumor Immunology Research at the UW Carbone Cancer Center.Dr. McNeel is a musician and spends his free time playing the pipe organ.My hope for each patient is that they find either a treatment or an outcome that works best for them and works best for their family. Long term, we want to use the ‘cure’ word more often for patients with cancer. And so that's my ultimate long-term goal. Dr. Mcneel is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Adult Soft Tissue Sarcoma, and Familial Prostate Cancer. Dr. Mcneel is board certified in Medical Oncology.